• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Utility of functional diffusion maps to monitor a patient diagnosed with gliomatosis cerebri.功能扩散图谱在监测脑胶质瘤患者中的效用。
J Neurooncol. 2010 May;97(3):419-23. doi: 10.1007/s11060-009-0018-y. Epub 2009 Oct 8.
2
Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab.基于功能梯度扩散映射定义的表观扩散系数特征可预测贝伐珠单抗治疗复发性胶质母细胞瘤的总生存期。
Neuro Oncol. 2011 Oct;13(10):1151-61. doi: 10.1093/neuonc/nor079. Epub 2011 Aug 19.
3
Quantitative probabilistic functional diffusion mapping in newly diagnosed glioblastoma treated with radiochemotherapy.定量概率功能扩散映射在新诊断的胶质母细胞瘤放化疗中的应用。
Neuro Oncol. 2013 Mar;15(3):382-90. doi: 10.1093/neuonc/nos314. Epub 2012 Dec 28.
4
Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade glioma.对7例高级别胶质瘤中表观扩散系数降低区域细胞增多和扩散受限坏死进行精确的离体组织学验证。
Neuro Oncol. 2014 Dec;16(12):1599-606. doi: 10.1093/neuonc/nou142. Epub 2014 Jul 24.
5
Fluid-attenuated inversion-recovery MR imaging of gliomatosis cerebri.大脑胶质瘤病的液体衰减反转恢复磁共振成像
Eur Radiol. 2001;11(2):303-8. doi: 10.1007/s003300000587.
6
Diffusion tensor tractography of gliomatosis cerebri: fiber tracking through the tumor.大脑胶质瘤病的扩散张量纤维束成像:通过肿瘤的纤维追踪
J Comput Assist Tomogr. 2005 Jan-Feb;29(1):127-9. doi: 10.1097/01.rct.0000148453.29579.51.
7
Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas.功能扩散图的容积分析是恶性胶质瘤细胞毒性和抗血管生成治疗的预测性成像生物标志物。
J Neurooncol. 2011 Mar;102(1):95-103. doi: 10.1007/s11060-010-0293-7. Epub 2010 Aug 27.
8
Predicting Glioblastoma Recurrence by Early Changes in the Apparent Diffusion Coefficient Value and Signal Intensity on FLAIR Images.通过磁共振液体衰减反转恢复序列(FLAIR)图像上表观扩散系数值和信号强度的早期变化预测胶质母细胞瘤复发
AJR Am J Roentgenol. 2017 Jan;208(1):57-65. doi: 10.2214/AJR.16.16234. Epub 2016 Oct 11.
9
Automated adjustment of display conditions in brain MR images: diffusion-weighted MRIs and apparent diffusion coefficient maps for hyperacute ischemic stroke.脑磁共振图像中显示条件的自动调整:超急性缺血性卒中的扩散加权磁共振成像和表观扩散系数图
Radiol Phys Technol. 2013 Jan;6(1):202-9. doi: 10.1007/s12194-012-0189-7. Epub 2012 Nov 27.
10
Gliomatosis cerebri.脑胶质瘤病。
Medicina (Kaunas). 2010;46(5):341-4.

引用本文的文献

1
Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma.动态对比剂磁共振成像测量相对脑血容量可预测复发性高级别胶质瘤对贝伐珠单抗的反应。
Neuro Oncol. 2014 Jun;16(6):880-8. doi: 10.1093/neuonc/not216. Epub 2014 Jan 15.
2
Gliomatosis cerebri: clinical characteristics, management, and outcomes.脑胶质瘤病:临床特征、治疗及预后。
J Neurooncol. 2013 Apr;112(2):267-75. doi: 10.1007/s11060-013-1058-x. Epub 2013 Jan 23.
3
Quantitative probabilistic functional diffusion mapping in newly diagnosed glioblastoma treated with radiochemotherapy.定量概率功能扩散映射在新诊断的胶质母细胞瘤放化疗中的应用。
Neuro Oncol. 2013 Mar;15(3):382-90. doi: 10.1093/neuonc/nos314. Epub 2012 Dec 28.
4
Presentation patterns and outcome of gliomatosis cerebri.大脑胶质瘤病的临床表现模式及预后
Oncol Lett. 2012 Jan;3(1):209-213. doi: 10.3892/ol.2011.445. Epub 2011 Oct 18.
5
Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma.功能扩散图(fDMs)在放化疗前后评估,可预测新诊断的胶质母细胞瘤的无进展生存期和总生存期。
Neuro Oncol. 2012 Mar;14(3):333-43. doi: 10.1093/neuonc/nor220. Epub 2012 Jan 22.
6
Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab.基于功能梯度扩散映射定义的表观扩散系数特征可预测贝伐珠单抗治疗复发性胶质母细胞瘤的总生存期。
Neuro Oncol. 2011 Oct;13(10):1151-61. doi: 10.1093/neuonc/nor079. Epub 2011 Aug 19.
7
Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment.前瞻性分析参数反应图衍生的 MRI 生物标志物:识别标准影像学评估无法预测的早期且独特的脑胶质瘤反应模式。
Clin Cancer Res. 2011 Jul 15;17(14):4751-60. doi: 10.1158/1078-0432.CCR-10-2098. Epub 2011 Apr 28.
8
Advances in MRI assessment of gliomas and response to anti-VEGF therapy.磁共振成像评估脑胶质瘤及抗血管内皮生长因子治疗反应的研究进展。
Curr Neurol Neurosci Rep. 2011 Jun;11(3):336-44. doi: 10.1007/s11910-011-0179-x.
9
Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas.功能扩散图的容积分析是恶性胶质瘤细胞毒性和抗血管生成治疗的预测性成像生物标志物。
J Neurooncol. 2011 Mar;102(1):95-103. doi: 10.1007/s11060-010-0293-7. Epub 2010 Aug 27.

本文引用的文献

1
Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.功能扩散图谱作为高级别胶质瘤的早期影像生物标志物:与传统放射学反应及总生存期的相关性
J Clin Oncol. 2008 Jul 10;26(20):3387-94. doi: 10.1200/JCO.2007.15.2363. Epub 2008 Jun 9.
2
The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome.功能扩散图谱:一种用于早期预测癌症治疗结果的影像生物标志物。
Neoplasia. 2006 Apr;8(4):259-67. doi: 10.1593/neo.05844.
3
Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma.评估功能扩散图谱作为高级别胶质瘤进展时间和总生存期的早期生物标志物。
Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16759-64. doi: 10.1073/pnas.0508347102. Epub 2005 Nov 2.
4
Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature.大脑胶质瘤病:来自ANOCEF数据库及文献的296例病例综述
J Neurooncol. 2006 Jan;76(2):201-5. doi: 10.1007/s11060-005-5263-0.
5
Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response.功能扩散图谱:一种用于临床脑肿瘤反应早期分层的非侵入性磁共振成像生物标志物。
Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5524-9. doi: 10.1073/pnas.0501532102. Epub 2005 Apr 1.
6
Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma.利用脑部质子磁共振波谱法鉴别大脑胶质瘤病与低级别胶质瘤。
J Neurosurg. 2003 Feb;98(2):269-76. doi: 10.3171/jns.2003.98.2.0269.
7
How often are nonenhancing supratentorial gliomas malignant? A population study.
Neurology. 2002 Sep 24;59(6):947-9. doi: 10.1212/wnl.59.6.947.
8
Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors.扩散磁共振成像:脑肿瘤治疗疗效的早期替代标志物。
J Natl Cancer Inst. 2000 Dec 20;92(24):2029-36. doi: 10.1093/jnci/92.24.2029.
9
Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging.通过扩散加权磁共振成像测量人黑色素瘤异种移植瘤中的细胞密度和坏死分数。
Magn Reson Med. 2000 Jun;43(6):828-36. doi: 10.1002/1522-2594(200006)43:6<828::aid-mrm8>3.0.co;2-p.
10
Real-time 3D image registration for functional MRI.功能磁共振成像的实时三维图像配准
Magn Reson Med. 1999 Dec;42(6):1014-8. doi: 10.1002/(sici)1522-2594(199912)42:6<1014::aid-mrm4>3.0.co;2-f.

功能扩散图谱在监测脑胶质瘤患者中的效用。

Utility of functional diffusion maps to monitor a patient diagnosed with gliomatosis cerebri.

机构信息

Translational Brain Tumor Program, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226, USA.

出版信息

J Neurooncol. 2010 May;97(3):419-23. doi: 10.1007/s11060-009-0018-y. Epub 2009 Oct 8.

DOI:10.1007/s11060-009-0018-y
PMID:19813078
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2956408/
Abstract

Diffusion-weighted magnetic resonance imaging (DWI) is a sensitive imaging biomarker for tumor cellularity. Functional diffusion maps (fDMs), which examine voxel-by-voxel changes in the apparent diffusion coefficient (ADC) calculated from serial DWIs, have previously been applied to regions of contrast-enhancement; however, application of fDMs to non-enhancing brain tumors has not been pursued. In this case study we demonstrate the utility of applying fDMs to regions of abnormal FLAIR signal intensity in a patient diagnosed with gliomatosis cerebri: a relatively rare, infiltrative, non-enhancing brain tumor. The absolute volume of hypercellularity extracted from fDMs was useful in tracking tumor growth, which correlated in time with a progressive decline in neurological status despite no change in traditional magnetic resonance images. Results of this study demonstrate the value of fDMs, applied to regions of FLAIR abnormal signal intensity, for localizing regions of hypercellularity and for monitoring overall tumor status.

摘要

弥散加权磁共振成像(DWI)是一种对肿瘤细胞密度敏感的影像学生物标志物。功能弥散图(fDMs)是通过对一系列 DWI 计算得出的表观扩散系数(ADC)的体素进行逐点分析,可以用来研究增强区域;然而,fDMs 尚未应用于非增强性脑肿瘤。在本病例研究中,我们展示了将 fDMs 应用于脑胶质瘤患者异常 FLAIR 信号强度区域的实用性:脑胶质瘤是一种相对罕见的浸润性非增强性脑肿瘤。从 fDMs 中提取的高细胞密度的绝对体积可用于跟踪肿瘤生长,尽管传统磁共振成像没有变化,但肿瘤生长与神经功能状态的逐渐下降相关。本研究结果表明,fDMs 应用于 FLAIR 异常信号强度区域对于定位高细胞密度区域和监测整体肿瘤状态具有重要价值。